Search Results - "Scherwitzl, Iris"

The alteration of NK cells phenotypes related to the functions and dengue disease outcomes by Taechasan, Napas, Scherwitzl, Iris, Supasa, Piyada, Dejnirattisai, Wanwisa, Sriruksa, Kanokwan, Limpitikul, Wannee, Malasit, Prida, Screaton, Gavin R, Mongkolsapaya, Juthathip, Duangchinda, Thaneeya

“…•The NKp30 receptor's expression on activated NK cells is more pronounced in DF patients than in DHF patients, suggesting a potential role of this receptor in…”
Get full text

Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody by Yu, Minjun, Scherwitzl, Iris, Opp, Silvana, Tsirigos, Aristotelis, Meruelo, Daniel

“…Limitations to current therapies for treating non-Hodgkin B cell lymphoma include relapse, toxicity and high cost. Thus, there remains a need for novel…”
Get full text

Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors by Scherwitzl, Iris, Opp, Silvana, Hurtado, Alicia M., Pampeno, Christine, Loomis, Cynthia, Kannan, Kasthuri, Yu, Minjun, Meruelo, Daniel

“…Despite remarkable responses to cancer immunotherapy in a subset of patients, many patients remain resistant to therapies. It is now clear that elevated levels…”
Get full text

Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity by Scherwitzl, Iris, Hurtado, Alicia, Pierce, Carolyn M., Vogt, Sandra, Pampeno, Christine, Meruelo, Daniel

“…Oncolytic viruses represent a promising form of cancer immunotherapy. We investigated the potential of Sindbis virus (SV) for the treatment of solid tumors…”
Get full text

Recent advances in human flavivirus vaccines by Scherwitzl, Iris, Mongkolsapaja, Juthathip, Screaton, Gavin

“…•No WNV and ZIKV vaccines are available for human use.•Some WNV vaccine candidates show promising results in phase II clinical trials.•First licensed DENV…”
Get full text

MAIT cells are activated during human viral infections by van Wilgenburg, Bonnie, Scherwitzl, Iris, Hutchinson, Edward C., Leng, Tianqi, Kurioka, Ayako, Kulicke, Corinna, de Lara, Catherine, Cole, Suzanne, Vasanawathana, Sirijitt, Limpitikul, Wannee, Malasit, Prida, Young, Duncan, Denney, Laura, Moore, Michael D., Fabris, Paolo, Giordani, Maria Teresa, Oo, Ye Htun, Laidlaw, Stephen M., Dustin, Lynn B., Ho, Ling-Pei, Thompson, Fiona M., Ramamurthy, Narayan, Mongkolsapaya, Juthathip, Willberg, Christian B., Screaton, Gavin R., Klenerman, Paul

“…Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize bacterial ligands. Here, we demonstrate that MAIT cells are also activated…”
Get full text

The role of genomic location and flanking 3′UTR in the generation of functional levels of variant surface glycoprotein in Trypanosoma brucei by Ridewood, Sophie, Ooi, Cher‐Pheng, Hall, Belinda, Trenaman, Anna, Wand, Nadina Vasileva, Sioutas, Georgios, Scherwitzl, Iris, Rudenko, Gloria

“…Summary Trypanosoma brucei faces relentless immune attack in the mammalian bloodstream, where it is protected by an essential coat of Variant Surface…”
Get full text

The role of genomic location and flanking 3'UTR in the generation of functional levels of variant surface glycoprotein in Trypanosoma brucei by Ridewood, Sophie, Ooi, Cher-Pheng, Hall, Belinda, Trenaman, Anna, Wand, Nadina Vasileva, Sioutas, Georgios, Scherwitzl, Iris, Rudenko, Gloria

“…Trypanosoma brucei faces relentless immune attack in the mammalian bloodstream, where it is protected by an essential coat of Variant Surface Glycoprotein…”
Get full text

The influence of mait cells and host genomic risk factors on dengue infection by Scherwitzl, Iris Claire

“…Dengue virus (DENV) is a rapidly emerging pathogen causing an estimated 100 million symptomatic infections annually. The clinical spectrum of dengue disease is…”
Get full text